METANOVA
@metanova_labs
Followers
3K
Following
3K
Media
84
Statuses
564
AI drug discovery company developing therapies to reprogram body+mind. decentralized by design. powered by NOVA - #Bittensor Subnet 68
Joined November 2024
Lilly hit a $1T market cap this week with ~80% driven by GLP-1s. the message is obvious: drugs that reprogram core biological behaviors (like metabolism and reward) become some of the most valuable tech on earth. this is the r+d thesis behind @metanova_labs. NOVA is the
Lilly hit $1T market cap this week, ~80% based on GLP1s this is the first existence proof that medicines that create health for ~everyone are among the most valuable products possible we will see more of these in the coming decades as preserving health is unlocked technically
3
9
53
we’re on track to scale + automate decentralized drug discovery with the help of our partners. this new tool pushes us closer to positioning NOVA as a marketplace for novel compounds for development by other companies and the upcoming coming wave of autonomous science agents.
This one matters for the real-world use case crowd. $TAO powered @metanova_labs SN68 on Bittensor, killing it. DiaGen is a Vancouver based AI drug discovery company founded in 2021. Twice selected as a Top 100 Canadian tech company at the All In AI event in Montreal. On stage
3
14
60
Starting in 30 mins! Join us as we discuss DeSci on Bittensor with special guest @metanova_labs, for the first installment of our Bittensor Spotlight series.
Join us this Thursday for Talisman Revelations: Bittensor Spotlight series w/ @metanova_labs We’ll explore how Metanova is pushing decentralized drug discovery forward via Bittensor SN68, and how Talisman helps onboards research into Web3.
18
20
81
Join us this Thursday for Talisman Revelations: Bittensor Spotlight series w/ @metanova_labs We’ll explore how Metanova is pushing decentralized drug discovery forward via Bittensor SN68, and how Talisman helps onboards research into Web3.
7
15
73
there are already >10M molecules in NOVA's libraries. far more than any human team could efficiently triage. the next unlock is automating how we filter through submissions. this Hit Picker would become the intelligence layer on top of NOVA: scoring, ranking, and extracting the
Metanova Labs x DiaGen AI Inc announcing new JV to develop a multi-objective Hit Picker for automating drug discovery today, Hit-picking is slow and manual with medicinal chemists reviewing ranked lists and relying on years of experience and intuition. together we’re building a
3
12
68
Metanova Labs x DiaGen AI Inc announcing new JV to develop a multi-objective Hit Picker for automating drug discovery today, Hit-picking is slow and manual with medicinal chemists reviewing ranked lists and relying on years of experience and intuition. together we’re building a
tech.einnews.com
Powered by the Bittensor $TAO Network, DiaGen Ai and Metanova Labs will Leverage Collective Intelligence to Accelerate R&D Toward Faster Commercialization
4
17
68
Here’s some more bedtime reading @metanova_labs @SwarmSubnet @bitsecai @leomercier @babelbit @Vericore_S70 $TAO
Every subnet has a story. Ask Savant: What problem is it solving? How do its incentives work? What’s its roadmap? Get the full picture via Savant or https://t.co/Ol8MtOI7vu UI 🤖 @qBitTensorLabs @zeussubnet @IOTA_SN9 @Data_SN13 @Eastworld_AI @level_114 $TAO
4
23
68
With the new taoflow update, if a subnet's normalized net flow is higher than their price, the chain will start buying those subnets so that the price converges to flow. We added a new column on taomarketcap that shows the daily buy pressure of the chain. Ex: 130 extra tao per
12
11
116
Nova Blueprint 🔎 ⚙️ validator + miner logs now live you can now view both validator logs and your own miner runtime logs directly in our new grafana dashboard. miner logs can be filtered by period and UID, making it easy to see exactly how your miner runs inside the
0
6
26
NOVA is existential technology a decentralized, self-improving engine exploring untapped chemical spaces to reprogram body + mind
0
11
64
Nova is one of the special teams fully dedicated to making their bittensor subnet revolutionize a multi billion $ industry. I met the team personally and am excited watch their progress.
Very excited to see Nova begin to take their molecules to further and further into production
4
7
76
first (and still the only) mover advantage. 7 months in and we have: - 2 incentive mechanisms running in parallel - 2 fine-tuned models - >65 B synthesizable molecules for screening - 5 combinatorial reactions for generating molecules - >10 M molecules in our libraries for
NOVA is the FIRST decentralized virtual drug screening platform in the world. in markets shaped by data, networks, and compounding intelligence, early entrants get to accumulate things that can’t easily be copied later: • technical learning curves • proprietary data +
6
9
80
NOVA is the FIRST decentralized virtual drug screening platform in the world. in markets shaped by data, networks, and compounding intelligence, early entrants get to accumulate things that can’t easily be copied later: • technical learning curves • proprietary data +
1
16
67
breakout 🤝 moonshot 1. molecules 2. search algorithms -> x vision? we're only getting started
to take on the giants you need composable, multi-dimensional bets across time and space. @webuildscore is stacking partnerships, use cases, and piercing through the echo chamber, fast-tracking the billion-dollar company building-project that ultimately can lift all tides.
0
4
30
what is the value of NOVA? @metanova_labs we’re constantly trying to translate the signals we see as the platform evolves and their future potential. time and cost savings are KPIs. market size helps predict demand. but the real value (investing in the existence of better
4
4
33
drug development doesn't happen overnight but the value generated is unparalleled. recent relevant deals & pipelines include: • @Novartis × CKD-510 (HDAC6, CMT) phase I asset licensed from Chong Kun Dang $80M upfront + >$1B milestones • Augustine Therapeutics (CMT &
NOVA_Compound: early validation a molecule submitted by NOVA miners shows high similarity to a HDAC 1/6 inhibitor patented by the Shanghai Pharmaceutical Industry Research Institute as a neuroprotective drug candidate. that means NOVA surfaced a molecule structurally and
1
7
32
more signal @metanova_labs
@UXBlockLab @metanova_labs sn68 showing real signal now that nova compound validation is legit. 0.8026 similarity to a patented hdac inhibitor means they surfaced something structurally comparable to actual pharma compounds. not theoretical anymore 430+ molecules in their library scoring similar or
0
1
15
great question! one of the reasons we’re excited about our target libraries, is that our data shows that NOVA's miners are surfacing a spectrum of molecules from multi-billion chemical spaces. from those highly similar to known actives (like the example in our post) to those
@metanova_labs Wow, this is so cool, amazing work. same pharmacophore architecture and predicted potency right on target. Makes me wonder how would NOVA navigate this legally, since the hydroxamate sulfonamide scaffold is in such a densely patented chemical space where a lot of modifications
1
4
20